Clinical trial
Clinical Study of AFN50 Injection in the Autoimmune Diseases
NCT07408336 is registered in ClinicalTrials.gov with AlphaNa Bioscience Company Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of AFN50 Injection in the Autoimmune Diseases
- Lead sponsor
- AlphaNa Bioscience Company Limited
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- February 4, 2026
- Completion date
- February 3, 2029
- Enrollment
- 18 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.